| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |